Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Sam Chun Dang Pharm Co., Ltd. (000250:KRX), powered by AI.
Sam Chun Dang Pharm Co., Ltd. is currently trading at ₩648,000. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Sam Chun Dang Pharm Co., Ltd. on Alpha Lenz.
Sam Chun Dang Pharm Co., Ltd.'s P/E ratio is -1366.3.
“Sam Chun Dang Pharm Co., Ltd. trades at a P/E of -1366.3 (undervalued) with modest ROE of -4.5%.”
Ask for details →Sam Chun Dang Pharm Co., Ltd. is a notable pharmaceutical company involved in the research, development, and production of various healthcare solutions. Founded in South Korea, the company focuses on creating a diverse array of pharmaceutical products that cater to the healthcare needs of a broad spectrum of patients. Their portfolio includes over-the-counter drugs, prescription medications, and a range of health supplements, demonstrating their commitment to improving public health and optimizing therapeutic outcomes. By participating actively in the pharmaceutical industry, Sam Chun Dang Pharm Co., Ltd. contributes significantly to the accessibility and availability of essential medications across regional and global markets. The company consistently invests in innovation and manufacturing excellence, ensuring compliance with international regulatory standards and thereby enhancing its market reputation. Its role in the healthcare sector is pivotal, as it addresses critical medical needs and supports the overall advancement of medical sciences.
“Sam Chun Dang Pharm Co., Ltd. trades at a P/E of -1366.3 (undervalued) with modest ROE of -4.5%.”
Ask for details →